Researchers at TRI are studying molecular mechanisms that contribute to metabolic and cardiovascular homeostasis in the body, to develop improved diagnosis and treatment options for conditions including diabetes and cardiovascular disease.

Metabolic and cardiovascular processes often become defective in obesity, resulting in the development of chronic diseases such as type 2 diabetes and cardiovascular disease. In vitro and in vivo systems are used together with a range of techniques involving molecular and cellular biology combined with biochemistry and ‘omics’ approaches to define molecular mechanisms that contribute to cardiometabolic health.

Key Researchers
Jon Whitehead
John Prins
Michael McGuckin
Emma Hamilton-Williams
Ranjeny Thomas
Show More ...
Key Aims
  • To identify novel strategies to reduce cardiometabolic disease.
International Clinical Trials Day: Q and A with TRI’s Steve Turner On International Clinical Trials Day on 20 May, we honour the incredibly hardworking professionals in the clinical trials...Read more
Gut reaction linked to type 1 diabetes Source: UQ News, 13 August 2018 Understanding the link between diabetes and the gut could lead to the development of new therapies to delay the onset of type 1...Read more
National Diabetes Week 2018 National Diabetes Week runs from 8 July to 14 July 2018. The week focuses on creating greater awareness of better and early detection for all types of diabetes. It is...Read more
Prestigious TJ Neale award presented to Mater Researcher TRI based Mater researcher, Professor Josephine Forbes, has been awarded the prestigious TJ Neale award by the Australia and New Zealand...Read more
QUT Leads world-first new treatment for alcohol addiction Alcohol addiction causes almost 3.8 per cent of deaths worldwide but a study led by QUT researchers offers new hope in the form of a drug...Read more
Treating sugar addiction like drug abuse: QUT leads world-first study With obesity rates on the rise worldwide and excess sugar consumption considered a direct contributor, the search has been on for...Read more
GutFull Event Wrap Up Last Wednesday, UQ's Diamantina Institute hosted an event at TRI focusing on Gut Microbiome - the good and bad bugs in our bodies. This free forum was part of a series...Read more
mri-uq discovery may revolutionise diabetes treatment A Queensland-based researcher is on the verge of a significant new approach to treatment for people with Type 2 diabetes. Professor Mike McGuckin...Read more
TALENTED TRI-BASED RESEARCHERS RECOGNISED AT WOMEN IN TECHNOLOGY AWARDS The outstanding work of TRI researchers has been recognised with two winners at the 17th Annual Women in Technology (WiT)...Read more